for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Avanos Medical Inc

AVNS.N

Latest Trade

33.04USD

Change

-0.93(-2.74%)

Volume

58,529

Today's Range

32.83

 - 

34.12

52 Week Range

19.50

 - 

48.07

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Avanos Medical Q2 Adjusted Earnings Per Share $0.13

Aug 4 (Reuters) - Avanos Medical Inc <AVNS.N>::AVANOS MEDICAL, INC. ANNOUNCES SECOND QUARTER 2020 RESULTS.Q2 ADJUSTED EARNINGS PER SHARE $0.13.Q2 LOSS PER SHARE $0.06.Q2 SALES $164 MILLION VERSUS REFINITIV IBES ESTIMATE OF $147.9 MILLION.Q2 EARNINGS PER SHARE ESTIMATE $-0.10 -- REFINITIV IBES DATA.CAUTIOUS ABOUT INCREASING NUMBER OF COVID-19 CASES AND ITS POTENTIAL IMPACT TO SLOW RECOVERY OF ELECTIVE PROCEDURES.NOW ANTICIPATE DISRUPTION FROM COVID-19 WILL CONTINUE INTO 2021.

Avanos Medical Inc Says Board Elected Gary Blackford As Chairman

May 6 (Reuters) - Avanos Medical Inc <AVNS.N>::AVANOS MEDICAL INC - CO'S CHAIRMAN OF BOARD, RON DOLLENS DID NOT SEEK RE-ELECTION IN 2020 AND RETIRED FROM BOARD EFFECTIVE IMMEDIATELY.AVANOS MEDICAL INC - BOARD ELECTED GARY BLACKFORD AS CHAIRMAN, EFFECTIVE IMMEDIATELY FOLLOWING ANNUAL MEETING.

Avanos Medical Reports Q1 Adjusted Earnings Per Share $0.16

May 6 (Reuters) - Avanos Medical Inc <AVNS.N>::AVANOS MEDICAL, INC. ANNOUNCES FIRST QUARTER 2020 RESULTS AND PROVIDES AN UPDATE ON ITS RESPONSE TO THE COVID-19 PANDEMIC.Q1 ADJUSTED EARNINGS PER SHARE $0.16.Q1 EARNINGS PER SHARE $0.08.Q1 SALES $180 MILLION VERSUS REFINITIV IBES ESTIMATE OF $175.2 MILLION.Q1 EARNINGS PER SHARE ESTIMATE $0.16 -- REFINITIV IBES DATA.COMPANY IS WITHDRAWING ITS PREVIOUSLY ANNOUNCED FULL-YEAR 2020 FINANCIAL GUIDANCE.SUSPENDING PLANNED 2020 MERIT INCREASES FOR ITS NON-MANUFACTURING, SALARIED EMPLOYEES.DECREASING DISCRETIONARY SPENDING ACROSS ORGANIZATION.POSTPONING CERTAIN CAPITAL EXPENDITURES AND RESEARCH AND DEVELOPMENT PROJECTS.STREAMLINING PROCESSES, WHILE LEAVING VACANT NON-CRITICAL POSITIONS OPEN.

Avanos Medical Appoints Michael Greiner As Chief Financial Officer

Dec 30 (Reuters) - Avanos Medical Inc <AVNS.N>::AVANOS MEDICAL APPOINTS MICHAEL C. GREINER AS CHIEF FINANCIAL OFFICER.AVANOS MEDICAL - GREINER, MOST RECENTLY SERVED AS CFO FOR ANGIODYNAMICS.

Avanos Medical, Inc. Announces Third Quarter 2019 Results, Completes Acquisition Of Endoclear Llc

Nov 5 (Reuters) - Avanos Medical Inc <AVNS.N>::AVANOS MEDICAL, INC. ANNOUNCES THIRD QUARTER 2019 RESULTS, COMPLETES ACQUISITION OF ENDOCLEAR LLC.Q3 ADJUSTED EARNINGS PER SHARE $0.30 FROM CONTINUING OPERATIONS.Q3 LOSS PER SHARE $0.24.Q3 SALES $171 MILLION VERSUS REFINITIV IBES ESTIMATE OF $179.8 MILLION.Q3 EARNINGS PER SHARE ESTIMATE $0.31 -- REFINITIV IBES DATA.REVISED ITS FULL-YEAR 2019 OUTLOOK FOR NET SALES GROWTH, IN CONSTANT CURRENCY, FROM 8 TO 10 PERCENT TO 5 TO 7 PERCENT.REVISED ITS FULL-YEAR 2019 OUTLOOK FOR ADJUSTED DILUTED EARNINGS PER SHARE FROM $1.15 TO $1.25 TO $1.00 TO $1.10.FY2019 EARNINGS PER SHARE VIEW $1.19, REVENUE VIEW $708.5 MILLION -- REFINITIV IBES DATA.

Avanos Medical, Inc. Announces Second Quarter 2019 Results

Aug 6 (Reuters) - Avanos Medical Inc <AVNS.N>::AVANOS MEDICAL, INC. ANNOUNCES SECOND QUARTER 2019 RESULTS, COMPLETES ACQUISITION OF NEOMED, INC., ANNOUNCES AGREEMENT TO ACQUIRE SUBSTANTIALLY ALL THE ASSETS OF SUMMIT MEDICAL PRODUCTS, INC., ANNOUNCES PARTNERSHIP AGREEMENT WITH BIOQ PHARMA.Q2 ADJUSTED EARNINGS PER SHARE $0.28 FROM CONTINUING OPERATIONS.Q2 LOSS PER SHARE $0.17.Q2 SALES $172 MILLION VERSUS REFINITIV IBES ESTIMATE OF $171.8 MILLION.Q2 EARNINGS PER SHARE ESTIMATE $0.25 -- REFINITIV IBES DATA.AVANOS MEDICAL - NOW EXPECTS FY NET SALES GROWTH OF 8 TO 10 PERCENT AND ADJUSTED DILUTED EARNINGS PER SHARE AT LOW-END OF ITS RANGE OF $1.15 TO $1.25..TO ACQUIRE SUBSTANTIALLY ALL ASSETS OF SUMMIT MEDICAL PRODUCTS INC. FOR APPROXIMATELY $18 MILLION.FY2019 EARNINGS PER SHARE VIEW $1.23, REVENUE VIEW $694.5 MILLION -- REFINITIV IBES DATA.

Avanos Medical Says Final Phase Of Multi-Year, Multi-Phase Restructuring Plan Approved - SEC Filing

June 18 (Reuters) - Avanos Medical Inc <AVNS.N>::AVANOS MEDICAL INC - ON JUNE 18, 2019, THIRD AND FINAL PHASE OF MULTI-YEAR, MULTI-PHASE RESTRUCTURING PLAN WAS APPROVED - SEC FILING.

Avanos Medical Inc Announces Tender Offer For Senior Notes

May 9 (Reuters) - Avanos Medical Inc <AVNS.N>::AVANOS MEDICAL, INC. ANNOUNCES TENDER OFFER FOR SENIOR NOTES.AVANOS MEDICAL - TO PURCHASE UP TO $129.8 MILLION IN AGGREGATE PURCHASE PRICE OF ITS OUTSTANDING 6.250 PERCENT SENIOR UNSECURED NOTES DUE OCTOBER 15, 2022.

Avanos Medical Posts Q1 Adjusted Earnings Per Share $0.15 From Continuing Operations

May 7 (Reuters) - Avanos Medical Inc <AVNS.N>::AVANOS MEDICAL, INC. ANNOUNCES FIRST QUARTER 2019 RESULTS.Q1 ADJUSTED EARNINGS PER SHARE $0.15 FROM CONTINUING OPERATIONS.Q1 LOSS PER SHARE $0.43.Q1 SALES ROSE 5 PERCENT TO $164 MILLION.REAFFIRMS FY 2019 ADJUSTED EARNINGS PER SHARE VIEW $1.15 TO $1.35.TOTAL DEBT AT END OF Q1 TOTALED $248 MILLION.MAINTAINS ITS FULL-YEAR 2019 ADJUSTED DILUTED EARNINGS PER SHARE OUTLOOK OF $1.15 TO $1.35.

Avanos Medical Appoints Warren Machan As Interim CFO

May 1 (Reuters) - Avanos Medical Inc <AVNS.N>::AVANOS MEDICAL INC - ON APRIL 25, 2019, APPOINTED WARREN J. MACHAN, AGE 53, TO SERVE AS INTERIM CFO, EFFECTIVE MAY 8, 2019 - SEC FILING.AVANOS MEDICAL INC - MACHAN WILL, ON AN INTERIM BASIS, SUCCEED STEVEN VOSKUIL, WHO, AS PREVIOUSLY DISCLOSED, NOTIFIED COMPANY OF HIS RESIGNATION.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up